Innovative Manufacturing Dedicated To The Cell And Gene Therapy Industry

For more than 25 years, the cell and gene therapy industry has revolutionized disease treatment. Aldevron has been at the forefront of these advancements, leveraging our expertise to turn your visions into reality. The development of these therapies comes with unique challenges, particularly within the complex manufacturing and regulatory environments.

As a premier Contract Development and Manufacturing Organization (CDMO) in the cell and gene therapy sector, we have supported over 1,000 clients in overcoming the hurdles of therapy development. Our commitment to continuous innovation enhances efficiency and safety, ensuring that patients can access these groundbreaking therapies sooner.